Skip to content
CNS Pulse
Pipeline
Indications
Companies
Targets
Readouts
Conferences
Abstracts
Authors
Home
Authors
David Walling
Presenting author
David Walling
1 presentation
T115. Open-label, randomized study to assess safety and efficacy of slow and accelerated switching to xanomeline/trospium from standard of care atypical antipsychotics in participants with schizophrenia
2026 ASCP Annual Meeting